Answers are grounded in this paper and cite their sources.
This is the first known report where intravitreal injection of ranibizumab was used as palliative treatment for refractory neovascular glaucoma due to iris metastasis.
No takes yet. Share an insight, caveat, or question.
Makri et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: